Liquidators of biotech startup in talks over stake in drug firm

Liquidators of biotech startup in talks over stake in drug firm
Synthase Biotech's trademarked enzyme Aloxsyn had been shown to improve the ability of cows to conceive. (Image: Unsplash)
Riley Kennedy
Liquidators of a collapsed animal-breeding startup are in talks about its stake in another drug development company.Set up in 2015, Synthase Biotech had developed a plant-based enzyme that stopped fats from going rancid.The Waikato-based company, which leased premises at AgResearch’s Ruakura campus in Hamilton, initially targeted artificial insemination for the global dairy industry and undertook its first capital raise of $800,000 in 2016.However, it collapsed in June last year after failing to find enough commercial contracts for its pr...

More Primary Sector

$55m deal secures Santana mining land
Primary Sector

$55m deal secures Santana mining land

The gold miner now owns all the land where its best mining prospects lie.  

Pattrick Smellie 17 Oct 2025
Fonterra’s fascinating exec incentive scheme
Opinion

Stock & Trade: Fonterra’s fascinating exec incentive scheme

Winston Peters has questioned bonuses linked to Fonterra’s $4.2b sale.

Stock & Trade 17 Oct 2025
Paeroa company switches on ‘world first’ seaweed biorefinery
Primary Sector

Paeroa company switches on ‘world first’ seaweed biorefinery

The tech behind the plant comes from a $1m Endeavour grant to Scion.

Greg Hurrell 17 Oct 2025